Medications for the treatment of obesity in adolescents
- PMID: 32523671
- PMCID: PMC7257846
- DOI: 10.1177/2042018820918789
Medications for the treatment of obesity in adolescents
Abstract
While there are eight medications/combinations approved for the treatment of obesity in adults, the options for the treatment of obesity in adolescents remain limited. Evidence for obesity medication use in adolescents is limited due to the relatively small number of clinical trials that have been completed and the few adolescents that have been included in many of the trials. The goal of this review will be to present the current evidence for the medications approved for adolescents, medications not approved for adolescents but have adolescent data, and medications approved for adults with the prospect for use in adolescents. We will also discuss current limitations and next steps in the exploration of future treatment options.
Keywords: adolescents; medications; obesity.
© The Author(s), 2020.
Conflict of interest statement
Conflict of interest statement: DSH has served as site principal investigator for clinical trials funded by Novo Nordisk and Vivus, Inc., with funds paid directly to his institution. No conflicts of interest exist for any of the authors.
References
-
- Pilitsi E, Farr OM, Polyzos SA, et al. Pharmacotherapy of obesity: available medications and drugs under investigation. Metabolism 2019; 92: 170–192. - PubMed
-
- World Health Organization. Obesity and overweight, https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight (2018, accessed 14 May 2019).
-
- Hales CM, Carroll MD, Fryar CD, et al. Prevalence of obesity among adults and youth: United States, 2015–2016. NCHS Data Brief 2017; 288: 1–8. - PubMed
-
- Centers for Disease Control and Prevention. Ten leading causes of death and injury, https://www.cdc.gov/injury/wisqars/LeadingCauses.html (2017, accessed 14 May 2019).
Publication types
LinkOut - more resources
Full Text Sources
